2nd Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$380,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act; Draft legislation, the Electronic Prescribing for Controlled Substances Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 501 (118th)

Medicare/Medicaid MMM

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 1967 (118th), S. 1038 (118th), S. 2129 (118th), H.R. 1613 (118th), H.R. 3281 (118th), S. 1491 (118th), H.R. 1770 (118th), H.R. 2880 (118th), H.R. 3282 (118th), H.R. 3561 (118th), S. 2052 (118th), H.R. 2816 (118th)

Pharmacy PHA

H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023; H.R. 382, the Pandemic is Over Act; H.R. 2679, the Pharmacy Benefits Manager Accountability Act; H.R. 3008, the Drug Shortage Prevention Act; S. 1339, the Pharmacy Benefits Manager Reform Act; S. 1542, the Delinking Revenue from Unfair Gouging Act; Draft legislation, To amend the Public Health Service Act to make updates to the Vaccine Injury Compensation Program; Draft legislation, To amend the Internal Revenue Code of 1986 to provide authority to add additional vaccines to the list of taxable vaccines.

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3008 (118th), H.R. 167 (118th), S. 1542 (118th), S. 1339 (118th), H.R. 382 (118th), H.R. 2679 (118th)

Taxation/Internal Revenue Code TAX

S. 1108, the Death Tax Repeal Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Internal Revenue Service (IRS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1108 (118th)

Labor Issues/Antitrust/Workplace LBR

S. 127, the PBM Transparency Act; S. 113, the Prescription Pricing for the People Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —
MATTHEW SEILER —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 127 (118th), S. 113 (118th)

Defense DEF

TRICARE pharmacy network changes; H.R. 2670, the Military Construction Authorization Act for Fiscal Year 2024

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2670 (118th)

Budget/Appropriations BUD

FY24 appropriations language request to fund FTC enforcement of the Robinson-Patman Act; FY24 appropriations report language to address pharmacy compounding; FY24 appropriations report language to address TRICARE pharmacy network

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.